Adaptimmune Therapeutics PLC

Wuxi Advanced Therapies Inc. is a global leader in advanced therapeutics, providing a comprehensive platform of services to support the development and commercialization of innovative therapies. With a commitment to excellence, the company operates multiple offices worldwide, including key locations in China, Switzerland, and the United States. Dedicated to advancing healthcare solutions, Wuxi Advanced Therapies leverages cutting-edge technology and expertise to facilitate the research and production of biologics and cell therapies. Their extensive network and resources enable them to meet the diverse needs of clients across the pharmaceutical and biotechnology sectors. Generated from the website

Iovance Biotherapeutics, based in Philadelphia, specializes in developing cutting-edge therapies for cancer treatment. Their focus lies in the research and development of investigational tumor infiltrating lymphocyte (TIL) therapy and peripheral blood lymphocyte (PBL) therapy. With a strong emphasis on clinical trials and advancing their pipeline, Iovance Biotherapeutics is dedicated to pushing the boundaries of cancer treatment to improve patient outcomes and quality of life. Generated from their website's infomation

Hava Health, Inc, based in Philadelphia, PA, is dedicated to revolutionizing the fight against nicotine addiction with their upcoming Hale Vaporizer system. Utilizing a patent-pending design, the device automatically reduces nicotine intake gradually over time, offering a clean and efficient solution for users. With a focus on simplicity and effectiveness, Hava Health ensures a seamless experience for users through a companion app, energy-efficient design, and connected technology that adjusts nicotine intake as needed. Committed to the highest manufacturing standards, the company aims to provide a cutting-edge solution to help individuals overcome nicotine addiction.Generated from the website